When a cancer center decides to add proton therapy to its radiation oncology department, it makes a long-term commitment to therapeutic innovation and high-quality patient care. A question remains essential: how to select the best proton therapy equipment provider, to ensure optimal installation and best-in-class performance throughout the system’s lifecycle?​

Does IBA support radiation oncology centers in improving their proton therapy journey? ​

How can we improve the environmental impact of cancer care in the growing context of climate change and worldwide ecological issues?
 

In the ever-evolving landscape of cancer treatment, can the future of cancer care be shaped by proton arc therapy with DynamicARC^®*?  ​

In the ever-evolving landscape of cancer treatment, how can cancer centers ensure they provide the most advanced proton therapy treatment and highest-quality patient care?

As a hospital executive, head of the radiotherapy department, radiation oncologist, medical physicist or radiotherapist, you may wonder if adding proton therapy treatment to your radiation oncology department can increase your hospital’s attractivity, improve cancer patient experience, and contribute to talent attraction and retention. ​

Dr. Lane Rosen, Director of Radiation Oncology at Willis Knighton Cancer Center in Shreveport, Louisiana, highlights the transformative impact of introducing proton therapy with the ProteusONE system at their facility. In this blog, he shares insights into how a community hospital can successfully implement proton therapy, traditionally reserved for larger academic centers. 

Proton therapy represents a significant advancement in radiation oncology. In this article, Dr. Craig Stevens, Chair of Radiation Oncology at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, discusses the evolution and benefits of their ProteusONE system installed in 2017.  

DynamicARC* represents a pivotal breakthrough in radiation therapy and in cancer treatment. In this blog, Dr. Craig Stevens, Professor and Chair of the Department of Radiation Oncology at William Beaumont Hospital, part of the Corewell Health System, emphasizes to what extent DynamicARC is key to the future of radiation therapy with protons, enabling a paradigm shift in cancer treatment.  

Prof. Barbara Alicja Jereczek-Fossa is Chair of Radiation Oncology at the European Institute of Oncology (IEO) in Milan and full Professor at the University of Milan, in Italy. She was elected President of the European Society for Radiotherapy and Oncology (ESTRO) in 2024 and her term is set to begin in 2026. ESTRO’s mission is to reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. Prof. Jereczek-Fossa, a highly respected radiation oncologist, brings decades of clinical experience, institutional leadership at the IEO, and a powerful vision for expanding access to precision therapies like proton therapy worldwide. This article highlights her view on proton therapy and the future of precision cancer care. 

Find out how ProteusONE at IEO Milan combines precision, patient comfort, and future-ready technology to set new standards in cancer care.